(Q44644292)

5 December 2017

Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis (English)

1 reference

5 December 2017

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

29 March 2024

author name string

J. Tyler Lonergan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600521

29 March 2024

R. Edward Barber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600521

29 March 2024

W. Christopher Mathews

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600521

29 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

5 December 2017

21 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14600521

full work available at URL

29 March 2024

http://journals.lww.com/00002030-200311210-00012

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

29 March 2024

1 reference

5 December 2017

17

1 reference

5 December 2017

17

1 reference

5 December 2017

2495-2499

1 reference

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

5 December 2017

1

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study

29 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors

29 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens

29 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy.

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway

29 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

29 March 2024

Molecular Pharmacology

10

39

625

Chen

1991

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

29 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

29 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases

29 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Symptomatic elevations of lactic acid and their response to treatment manipulation in human immunodeficiency virus-infected persons: a case series

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

Management of hyperlactatemia: no need for routine lactate measurements

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00002030-200311210-00012

29 March 2024

Identifiers

1 reference

5 December 2017

1 reference